Bill Text

Bill Information


PDF |Add To My Favorites |Track Bill | print page

AB-1943 Insulin affordability.(2019-2020)

SHARE THIS:share this bill in Facebookshare this bill in Twitter
Date Published: 01/16/2020 09:00 PM
AB1943:v99#DOCUMENT


CALIFORNIA LEGISLATURE— 2019–2020 REGULAR SESSION

Assembly Bill
No. 1943


Introduced by Assembly Member Grayson

January 16, 2020


An act relating to insulin.


LEGISLATIVE COUNSEL'S DIGEST


AB 1943, as introduced, Grayson. Insulin affordability.
Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health insurance policy issued, amended, delivered, or renewed on or after January 1, 2000, to include coverage for specified equipment and supplies for the management and treatment of insulin-using diabetes, non-insulin-using diabetes, and gestational diabetes as medically necessary, even if the items are available without a prescription. Existing law requires a health insurance policy issued, amended, delivered, or renewed on or after January 1, 2000, that covers prescription benefits to include coverage for specified diabetes management prescription items, including insulin and glucagon. Under existing law, coinsurance and deductibles for insulin and related necessary supplies are limited to those established for similar benefits within a given policy.
This bill would state the intent of the Legislature to enact legislation that would help ensure that insulin is available and affordable to all Californians.
Vote: MAJORITY   Appropriation: NO   Fiscal Committee: NO   Local Program: NO  

The people of the State of California do enact as follows:


SECTION 1.

 The Legislature finds and declares all of the following:
(a) Thirty million Americans are diagnosed with diabetes, including over 2,500,000 in California. Additionally, prediabetes or undiagnosed diabetes affects more than 13,000,000 adults in California, including one-third of adults 18 to 39 years of age. In California, the prevalence of diabetes has increased 35 percent in the last 10 years.
(b) Nationwide, average medical expenses are 2.3 times higher for those with diabetes. California’s total health care costs for treatment of diabetes is approximately $24.5 billion per year. One national study indicates that improving medication adherence among people with diabetes could prevent nearly 700,000 emergency department visits, 341,000 hospitalizations, and save $4.7 billion annually.
(c) Diabetes also increases a person’s risk for other serious health problems, including heart attack, stroke, blindness, kidney failure, amputations, and death. In California, the majority of the 13,000 limb amputations that occur each year are due to diabetes-related complications like infection and peripheral arterial disease.
(d) Insulin is a life-saving drug that has supported many Americans in the fight against diabetes. However, some Californians must pay hundreds of dollars a month in out-of-pocket costs. Diabetes is the single most expensive chronic condition in the United States. Between 2002 and 2013, the average price of insulin nearly tripled nationally, creating financial hardship for those who need insulin. In an American Diabetes Association study, 27 percent of respondents stated that insulin costs have affected their purchase or use of insulin in the past year.

SEC. 2.

 It is the intent of the Legislature to enact legislation that would take steps to ensure that insulin is available and affordable for all Californians.